182 related articles for article (PubMed ID: 14510999)
1. Eumelanin and phaeomelanin contents of depigmented and repigmented skin in vitiligo patients.
Parsad D; Wakamatsu K; Kanwar AJ; Kumar B; Ito S
Br J Dermatol; 2003 Sep; 149(3):624-6. PubMed ID: 14510999
[TBL] [Abstract][Full Text] [Related]
2. Eumelanin and phaeomelanin contents of human epidermis and cultured melanocytes.
Hunt G; Kyne S; Ito S; Wakamatsu K; Todd C; Thody A
Pigment Cell Res; 1995 Aug; 8(4):202-8. PubMed ID: 8610071
[TBL] [Abstract][Full Text] [Related]
3. Nle4DPhe7 alpha-melanocyte-stimulating hormone increases the eumelanin:phaeomelanin ratio in cultured human melanocytes.
Hunt G; Kyne S; Wakamatsu K; Ito S; Thody AJ
J Invest Dermatol; 1995 Jan; 104(1):83-5. PubMed ID: 7798647
[TBL] [Abstract][Full Text] [Related]
4. Phaeomelanin versus eumelanin as a chemical indicator of ultraviolet sensitivity in fair-skinned subjects at high risk for melanoma: a pilot study.
Vincensi MR; d'Ischia M; Napolitano A; Procaccini EM; Riccio G; Monfrecola G; Santoianni P; Prota G
Melanoma Res; 1998 Feb; 8(1):53-8. PubMed ID: 9508377
[TBL] [Abstract][Full Text] [Related]
5. An objective assessment of melanin in vitiligo skin treated with Balneo PUVA therapy.
Hegyi V; Petrovajová M; Novotný M
Skin Res Technol; 2014 Feb; 20(1):108-15. PubMed ID: 23800185
[TBL] [Abstract][Full Text] [Related]
6. Effect of PUVA therapy on melanocytes and keratinocytes in non-segmental vitiligo: histopathological, immuno-histochemical and ultrastructural study.
Anbar TS; El-Sawy AE; Attia SK; Barakat MT; Moftah NH; El-Ammawy TS; Abdel-Rahman AT; El-Tonsy MH
Photodermatol Photoimmunol Photomed; 2012 Feb; 28(1):17-25. PubMed ID: 22211999
[TBL] [Abstract][Full Text] [Related]
7. Development of an integrated method of skin phenotype measurement using the melanins.
Zanetti R; Prota G; Napolitano A; Martinez C; Sancho-Garnier H; Østerlind A; Sacerdote C; Rosso S
Melanoma Res; 2001 Dec; 11(6):551-7. PubMed ID: 11725201
[TBL] [Abstract][Full Text] [Related]
8. Pheomelanin as well as eumelanin is present in human epidermis.
Thody AJ; Higgins EM; Wakamatsu K; Ito S; Burchill SA; Marks JM
J Invest Dermatol; 1991 Aug; 97(2):340-4. PubMed ID: 2071942
[TBL] [Abstract][Full Text] [Related]
9. Autografting and PUVA. A combination therapy for vitiligo.
Skouge JW; Morison WL; Diwan RV; Rotter S
J Dermatol Surg Oncol; 1992 May; 18(5):357-60. PubMed ID: 1607458
[TBL] [Abstract][Full Text] [Related]
10. Melanocytes are not absent in lesional skin of long duration vitiligo.
Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
[TBL] [Abstract][Full Text] [Related]
11. Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin.
Abdel Naser MB; Wollina U; El Okby M; El Shiemy S
Clin Exp Dermatol; 2004 Jul; 29(4):380-2. PubMed ID: 15245535
[TBL] [Abstract][Full Text] [Related]
12. Quantitative analysis of eumelanin and pheomelanin in humans, mice, and other animals: a comparative review.
Ito S; Wakamatsu K
Pigment Cell Res; 2003 Oct; 16(5):523-31. PubMed ID: 12950732
[TBL] [Abstract][Full Text] [Related]
13. Topical calcipotriol as monotherapy and in combination with psoralen plus ultraviolet A in the treatment of vitiligo.
Ameen M; Exarchou V; Chu AC
Br J Dermatol; 2001 Sep; 145(3):476-9. PubMed ID: 11531840
[TBL] [Abstract][Full Text] [Related]
14. Spectroscopic assessment of dermal melanin using blue vitiligo as an in vivo model.
Hamzavi I; Shiff N; Martinka M; Huang Z; McLean D; Zeng H; Lui H
Photodermatol Photoimmunol Photomed; 2006 Feb; 22(1):46-51. PubMed ID: 16436181
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of melanocyte content in different zones of vitiligo lesions using the Melan-A marker.
Kubanov A; Proshutinskaia D; Volnukhin V; Katunina O; Abramova T
Acta Dermatovenerol Alp Pannonica Adriat; 2016; 25(1):5-9. PubMed ID: 27014772
[TBL] [Abstract][Full Text] [Related]
16. Transplantation of melanocytes in vitiligo.
Olsson MJ; Juhlin L
Br J Dermatol; 1995 Apr; 132(4):587-91. PubMed ID: 7748750
[TBL] [Abstract][Full Text] [Related]
17. Clinical and histopathologic characteristics of trichrome vitiligo.
Hann SK; Kim YS; Yoo JH; Chun YS
J Am Acad Dermatol; 2000 Apr; 42(4):589-96. PubMed ID: 10727303
[TBL] [Abstract][Full Text] [Related]
18. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans.
Valverde P; Healy E; Jackson I; Rees JL; Thody AJ
Nat Genet; 1995 Nov; 11(3):328-30. PubMed ID: 7581459
[TBL] [Abstract][Full Text] [Related]
19. Vitiligo: is it grace or curse?
Bakry OA; Hammam MA; Abdel Wahed MM
Acta Dermatovenerol Croat; 2013; 21(2):71-9. PubMed ID: 24001413
[TBL] [Abstract][Full Text] [Related]
20. Randomized double-blind trial of treatment of vitiligo: efficacy of psoralen-UV-A therapy vs Narrowband-UV-B therapy.
Yones SS; Palmer RA; Garibaldinos TM; Hawk JL
Arch Dermatol; 2007 May; 143(5):578-84. PubMed ID: 17519217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
